News & Events about Elanco Animal Health Inc.
Elanco Animal Health (NYSE:ELAN Get Rating) had its target price lowered by Morgan Stanley from $20.00 to $19.00 in a research note published on Monday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities research analysts also ...
Shares of Elanco Animal Health Incorporated (NYSE:ELAN Get Rating) have been assigned a consensus rating of Hold from the eight analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell ...
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET. A live audio webcast will be...
Today Elanco Animal Health (NYSE:ELAN) announced the U.S. Food and Drug Administration (FDA) approved Bexacat (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elancos innovative feline portfolio...
Ticker Report
5 months ago
Northwestern Mutual Wealth Management Co. increased its holdings in shares of Elanco Animal Health Incorporated (NYSE:ELAN Get Rating) by 147.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,...